Brand Name:

MYRICA GP2

MYRICA GP2 Tablet | Glimepiride 2 mg + Pioglitazone 15 mg + Metformin 500 mg SR

Categories:

TABLETS
Cardiac Diabetic
Contains Glimepiride 2 mg Contains Pioglitazone 15 mg Contains Metformin 500 mg SR Triple-combination therapy for Type 2 Diabetes Supports insulin secretion Helps improve insulin sensitivity Helps reduce hepatic glucose production Sustained-release Metformin formulation Use only as prescribed by a healthcare professional
MYRICA GP2 Tablet combines Glimepiride 2 mg, Pioglitazone 15 mg, and Metformin 500 mg SR for blood glucose management in adults with Type 2 Diabetes. Glimepiride supports insulin release, Pioglitazone improves insulin sensitivity, while Metformin helps reduce hepatic glucose production. This combination provides complementary action for glycemic control. Take MYRICA GP2 only as prescribed by your healthcare professional, alongside recommended diet and lifestyle measures.
Glimipride 2 Mg, Pioglitazone 15 Mg, Metformin (Sr) 500 Mg

Contact Us To Accelerate Your Journey To Market